Researchers have, for the first time, found that angiotensin receptor blockers — a particular class of anti-hypertensive medicines — are associated with a striking decrease in the occurrence and progression of dementia.
Researchers have, for the first time, found that angiotensin receptor blockers — a particular class of anti-hypertensive medicines — are associated with a striking decrease in the occurrence and progression of dementia.